Full study in the link below
1. **Background**: Hijama (bloodletting cupping therapy) is practiced as a traditional alternative medicine in various cultures. Its efficacy in treating hypertension has been debated.
2. **Materials and Methods**: This retrospective study analyzed data from 60 hypertensive patients aged 40-60 years with systolic blood pressure (SBP) ≥ 140 mm Hg. Thirty patients underwent Hijama therapy (study group) while 30 received conventional treatment (control group).
3. **Results**: After three sessions of Hijama, there was a significant reduction in SBP (from 149.2 to 130.8 mm Hg, p < 0.01). However, the reduction in diastolic blood pressure (DBP) was not significant (p = 0.074). The study group showed a mean SBP 9.6 mm Hg lower than the control group (130.8 vs. 140.4 mm Hg, p = 0.019), but DBP did not differ significantly between groups (87.0 vs. 86.0 mm Hg, p = 0.75).
4. **Conclusions**: The study suggests a clear association between Hijama therapy and reduced SBP in hypertensive patients. It proposes that Hijama can complement conventional therapy, potentially allowing for lower doses of antihypertensive drugs.
5. **Discussion**: The study highlights the need for larger, controlled trials to further investigate Hijama's efficacy, particularly its long-term effects and mechanisms of action.
6. **Recommendations**: Future studies should focus on larger sample sizes and longer follow-up periods to validate the sustained benefits of Hijama therapy in managing hypertension.
These points summarize the findings and implications of the study regarding the use of Hijama therapy in treating hypertension.
Comments